IS047 POSTSURGICAL MORBIDITY AND MORTALITY FAVORABLY INFORMS DEEP BRAIN STIMULATION FOR NEW INDICATIONS INCLUDING SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER

IF 3.2 3区医学 Q2 CLINICAL NEUROLOGY

Neuromodulation Pub Date : 2025-01-01 DOI:10.1016/j.neurom.2024.09.056

Judith Gault PhD , Patrick Hosokawa MSc , Daniel Kramer MD , Elyn Saks PhD , Paul Appelbaum MD , John Thompson PhD , Ann Olincy MD , Nicola Cascella MD , Akira Sawa MD , Wayne Goodman MD , Nidal Moukaddam MD , Sameer A. Sheth MD , William Anderson MD , Rachel A. Davis MD

引用次数: 0

查看原文本刊更多论文

Is047术后发病率和死亡率有利于深部脑刺激治疗新的适应症，包括精神分裂症和分裂情感性障碍

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuromodulation 医学-临床神经学

CiteScore

6.40

自引率

3.60%

发文量

978

审稿时长

54 days

期刊介绍： Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.